Atara Biotherapeutics Analyst Ratings

BenzingaDec 20 07:59 ET · Ratings

Rodman & Renshaw Initiates Coverage on Atara Biotherapeutics With Buy Rating, $25 Price Target

MT NewswiresDec 20 07:12 ET · Ratings

Kyverna Therapeutics Picks Former Atara Bio, Kite Executives for Leadership Roles

MT NewswiresDec 13 16:50 ET

Updated Results of Phase 3 ALLELE Study Presented at 66th American Society of Hematology Annual Meeting Confirm Efficacy, Safety and Durability of Novel Allogeneic Cell Therapy Tabelecleucel in Relapsed or Refractory Epstein-Barr Virus Positive...

PR NewswireDec 7 12:33 ET

Atara Biotherapeutics to Participate at the 7th Annual Evercore ISI HealthCONx Conference

BusinesswireNov 27 16:01 ET

Insider Sale: EVP of $ATRA (ATRA) Sells 1,000 Shares

Quiver QuantitativeNov 20 18:16 ET